サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1650894

がん診断薬の世界市場

Cancer Diagnostics

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
がん診断薬の世界市場
出版日: 2025年02月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

がん診断薬の世界市場は2030年までに3,361億米ドルに到達

2024年に2,398億米ドルと推定されるがん診断薬の世界市場は、2024年から2030年にかけてCAGR 5.8%で成長し、2030年には3,361億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである画像診断は、CAGR 6.8%を記録し、分析期間終了までに953億米ドルに達すると予測されます。臨床検査分野の成長率は、分析期間中CAGR 4.1%と推定されます。

米国市場は625億米ドルと推定、中国はCAGR 8.8％で成長予測

米国のがん診断薬市場は2024年に625億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに779億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と5.3%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界のがん診断薬市場- 主要動向と促進要因のまとめ

なぜがん診断薬は医療イノベーションの最前線にいるのか？

がん診断薬はヘルスケアにおける重要な分野であり、がんの早期発見、診断、モニタリングに不可欠なツールを提供し、患者の転帰を大幅に改善します。がんを正確かつ早期に診断する能力は、治療の成功率や生存率に大きな違いをもたらします。長年にわたり、がん診断薬は基本的な画像診断技術から高度に洗練された分子・遺伝子検査へと発展し、特定のがん種やその進行度、治療方針の決定に影響を及ぼす可能性のある遺伝子変異の同定を可能にしてきました。生検、血液検査、画像診断（MRIやCTスキャンなど）、ゲノム・プロファイリングなどの様々な診断技術の統合により、臨床医は患者のがんを包括的に把握することができます。さらに、リキッドバイオプシーや次世代シークエンシング（NGS）の進歩は、早期がんの発見とモニタリングの方法を一変させました。この分野の進歩に伴い、がん診断薬はより正確で個別化されたものとなり、治療戦略の形成や患者の生存率の向上に重要な役割を果たしています。

技術革新はどのようにがん診断薬を動かしているのか？

技術革新の急速なペースは、より正確で早期発見を可能にする新しいツールや手法をもたらし、がん診断薬の状況を大きく変えています。最も重要な開発のひとつは、ゲノム診断や分子診断の台頭であり、がん増殖の原動力となっている遺伝子変異についての洞察を提供しています。次世代シークエンシング（NGS）は、患者の遺伝子プロファイルの包括的な分析を可能にし、臨床医が個々のがん特有の特徴に合わせた治療を行うのを助け、個別化医療を現実のものにします。リキッドバイオプシーもまた最先端の進歩であり、簡単な血液検査でがんを発見することができます。この技術は早期発見だけでなく、がんの進行度や治療効果のモニタリングにも役立ちます。人工知能（AI）と機械学習も、画像診断技術を強化し、がん検診の精度を向上させ、複雑なデータセットをかつてないスピードで解釈できるようにすることで、その威力を発揮しています。これらの技術革新は、診断プロセスを合理化し、早期発見を可能にし、より正確で個別化された治療アプローチによって患者の転帰を向上させる。

がん診断薬の新たな動向と課題は？

現在、がん診断薬市場を形成しているいくつかの重要な動向があり、それぞれががんの発見と管理方法に影響を与えています。大きな動向は、リキッドバイオプシーや高度な画像診断技術など、患者の不快感を最小限に抑え、結果を得るのに必要な時間を短縮する非侵襲的診断に対する需要の高まりです。このような低侵襲的な方法へのシフトは、患者もヘルスケアプロバイダーも同様に、より安全で便利な選択肢を求めていることから、支持を集めています。もうひとつの動向は、がん検診が生命を救う可能性があるという認識が高まり、早期発見が重視されるようになったことです。乳がん、大腸がん、肺がんなどの検診プログラムが拡大し、がんを早期発見できる診断ツールの需要が高まっています。しかし、この分野はいくつかの課題にも直面しています。特に中低所得地域では、高度な診断技術の複雑さとコストが普及の障壁となる可能性があります。さらに、ゲノム検査や画像診断によって生成される膨大な量のデータは、高度なデータ管理・解析システムを必要とし、医療提供者にとっては統合や解釈の面で課題となります。このような課題にもかかわらず、個別化医療と早期発見を目指す動向は、がん診断薬.Genomeのイノベーションを推進し続けています。

がん診断薬市場拡大の要因は？

がん診断薬市場の成長は、主に技術の進歩、がん罹患率の上昇、早期発見と個別化治療の重視の高まりなど、いくつかの要因によってもたらされます。主な成長要因の1つは、分子診断、特に次世代シーケンシング（NGS）およびリキッドバイオプシー技術に対する需要の急増であり、これらはがんを検出するためのより正確で侵襲性の低い選択肢を提供します。また、個人の遺伝子プロファイルに合わせて治療計画を立てる個別化医療の普及も、特定のバイオマーカーや変異を特定できる診断ツールの需要に拍車をかけています。さらに、人口の高齢化や生活習慣に関連する危険因子などの要因によって、世界のがん罹患率の上昇も、がんを早期に発見して患者の転帰を改善できる診断ソリューションの必要性を高めています。また、定期的ながん検診を推進する政府の取り組みやヘルスケア政策も、特に新興国市場における診断検査への需要を促進しています。また、人工知能や機械学習が画像診断やデータ分析に統合され、がん検出の精度とスピードが向上していることも、市場成長を促す大きな要因となっています。これらの要因は、新興市場への診断機能の継続的な拡大と相まって、がん診断薬業界の急速な成長を今後数年間維持すると予想されます。

セグメント

タイプ（画像診断、ラボ検査、遺伝子検査、内視鏡検査、生検、その他のタイプ）;アプリケーション（乳房、肺、血液、大腸直腸、皮膚、前立腺、卵巣、その他のアプリケーション）

調査対象企業の例（注目の47社）

  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP10863

Global Cancer Diagnostics Market to Reach US$336.1 Billion by 2030

The global market for Cancer Diagnostics estimated at US$239.8 Billion in the year 2024, is expected to reach US$336.1 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$62.5 Billion While China is Forecast to Grow at 8.8% CAGR

The Cancer Diagnostics market in the U.S. is estimated at US$62.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$77.9 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Cancer Diagnostics Market - Key Trends and Drivers Summarized

Why Is Cancer Diagnostics at the Forefront of Medical Innovation?

Cancer diagnostics is a critical field within healthcare, providing essential tools for the early detection, diagnosis, and monitoring of cancer, significantly improving patient outcomes. The ability to diagnose cancer accurately and at an early stage can make a tremendous difference in treatment success rates and survival. Over the years, cancer diagnostics has evolved from basic imaging techniques to highly sophisticated molecular and genetic testing, enabling the identification of specific cancer types, their progression, and genetic mutations that may influence treatment decisions. The integration of various diagnostic technologies, such as biopsy, blood tests, imaging modalities (like MRI and CT scans), and genomic profiling, provides clinicians with a comprehensive view of a patient’s cancer. Moreover, advancements in liquid biopsy and next-generation sequencing (NGS) have transformed how early-stage cancer is detected and monitored. As the field advances, cancer diagnostics is becoming more precise and personalized, playing a crucial role in shaping treatment strategies and improving patient survival rates.

How Are Technological Innovations Driving Cancer Diagnostics?

The rapid pace of technological innovation is profoundly reshaping the cancer diagnostics landscape, bringing forth new tools and methodologies that allow for more accurate and earlier detection. One of the most significant developments has been the rise of genomic and molecular diagnostics, which provide insights into the genetic mutations driving cancer growth. Next-generation sequencing (NGS) enables the comprehensive analysis of a patient’s genetic profile, helping clinicians tailor treatments to the individual’s unique cancer characteristics, making personalized medicine a reality. Liquid biopsy, another cutting-edge advancement, allows for the detection of cancer through a simple blood test, offering a less invasive and faster alternative to traditional tissue biopsies. This technology is not only useful for early detection but also for monitoring cancer progression and treatment efficacy. Artificial intelligence (AI) and machine learning are also making their mark by enhancing imaging technologies, improving the accuracy of cancer screening, and allowing for the interpretation of complex datasets at an unprecedented speed. These innovations are streamlining diagnostic processes, enabling earlier detection, and facilitating better patient outcomes through more precise, individualized treatment approaches.

What Are the Emerging Trends and Challenges in Cancer Diagnostics?

Several key trends are currently shaping the cancer diagnostics market, each influencing how cancer is detected and managed. A major trend is the increasing demand for non-invasive diagnostics, such as liquid biopsy and advanced imaging techniques, which minimize patient discomfort and reduce the time needed to obtain results. This shift towards minimally invasive methods is gaining traction as patients and healthcare providers alike look for safer and more convenient options. Another trend is the growing emphasis on early detection, driven by rising awareness of cancer screening's life-saving potential. Screening programs for cancers such as breast, colorectal, and lung have expanded, leading to increased demand for diagnostic tools that can catch cancer at its earliest stages. However, the field faces several challenges as well. The complexity and cost of advanced diagnostic technologies can pose barriers to widespread adoption, particularly in low- and middle-income regions. Moreover, the sheer volume of data generated by genomic testing and imaging requires sophisticated data management and analysis systems, posing a challenge for healthcare providers in terms of integration and interpretation. Despite these challenges, the trend towards personalized medicine and early detection continues to propel innovation in cancer diagnostics.

What Factors Are Fueling the Expansion of the Cancer Diagnostics Market?

The growth in the cancer diagnostics market is driven by several factors, primarily advances in technology, rising cancer prevalence, and the increasing emphasis on early detection and personalized treatment. One of the key growth drivers is the surge in demand for molecular diagnostics, particularly next-generation sequencing (NGS) and liquid biopsy technologies, which provide more accurate and less invasive options for detecting cancer. The growing adoption of personalized medicine, where treatment plans are tailored to the individual’s genetic profile, has also spurred demand for diagnostic tools that can identify specific biomarkers and mutations. Additionally, the rising global incidence of cancer, driven by factors such as aging populations and lifestyle-related risk factors, is increasing the need for diagnostic solutions that can detect cancer early and improve patient outcomes. Government initiatives and healthcare policies promoting regular cancer screenings have also fueled the demand for diagnostic tests, particularly in developed markets. Another significant factor driving market growth is the integration of artificial intelligence and machine learning into diagnostic imaging and data analysis, which enhances the accuracy and speed of cancer detection. These factors, combined with the continued expansion of diagnostic capabilities into emerging markets, are expected to sustain the rapid growth of the cancer diagnostics industry in the years to come.

SCOPE OF STUDY:

The report analyzes the Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy, Other Types); Application (Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Globally Spurs Growth in Demand for Cancer Diagnostics
    • Technological Advancements in Genomics Throw the Spotlight on Precision Cancer Diagnostics
    • Growth in Personalized Medicine Expands Addressable Market Opportunity for Advanced Diagnostic Tools
    • Increasing Focus on Early Detection Propels Adoption of Non-Invasive Cancer Diagnostic Techniques
    • Growing Use of Liquid Biopsy Accelerates Demand for Minimal Invasive Cancer Diagnostic Methods
    • Expanding Applications of Biomarker Testing Sustain Growth in Cancer Diagnostics
    • Innovations in Imaging and Screening Generate New Opportunities for Early Cancer Detection
    • Shift toward Point-of-Care Diagnostics Strengthens Demand for Portable Cancer Diagnostic Tools
    • Growth in Molecular Diagnostics Expands Market Potential for Targeted Cancer Screening
    • Growing Use of Next-Generation Sequencing Accelerates Precision Cancer Diagnostics Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Skin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Skin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ovarian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 39: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 42: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 43: World Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: India Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Cancer Diagnostics by Application - Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Cancer Diagnostics by Application - Percentage Breakdown of Value Sales for Breast, Lung, Blood, Colorectal, Skin, Prostate, Ovarian and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Cancer Diagnostics by Type - Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Cancer Diagnostics by Type - Percentage Breakdown of Value Sales for Imaging, Laboratory Tests, Genetic Tests, Endoscopy, Biopsy and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION